Integrated Filing — IndAS

General information about company
Scrip Code	532843
NSE Symbol	FORTIS
MSEI Symbol	NOTLISTED
ISIN	INE061F01013
Name of company	Fortis Healthcare Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	20-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	08-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	20-May-2025   09:30:00
End date and time of board meeting	20-May-2025   18:55:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	20072000000	77827500000
	Other income	198000000	669400000
	Total income	20270000000	78496900000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	4595800000	18380700000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	34400000	-78800000
(d)	Employee benefit expense	2872900000	11672400000
(e)	Finance costs	675600000	1844100000
(f)	Depreciation, depletion and amortisation expense	1022300000	3856100000
(f)	Other Expenses
1	Professional and consultation fees to Doctors	4145400000	16306200000
2	Other Expenses	4068800000	15667600000
	Total other expenses	8214200000	31973800000
	Total expenses	17415200000	67648300000
3	Total profit before exceptional items and tax	2854800000	10848600000
4	Exceptional items	-535700000	-893400000
5	Total profit before tax	2319100000	9955200000
6	Tax expense
7	Current tax	344000000	1822400000
8	Deferred tax	141300000	154200000
9	Total tax expenses	485300000	1976600000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	1833800000	7978600000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	46400000	115200000
16	Total profit (loss) for period	1880200000	8093800000
17	Other comprehensive income net of taxes	-30400000	-35200000
18	Total Comprehensive Income for the period	1849800000	8058600000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	1838900000	7742100000
	Total profit or loss, attributable to non-controlling interests	41300000	41300000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-29600000	-32100000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	-800000	-3100000
21	Details of equity share capital
	Paid-up equity share capital	7549600000	7549600000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		81615600000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	2.44	10.26
	Diluted earnings (loss) per share from continuing operations	2.44	10.26
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	2.44	10.26
	Diluted earnings (loss) per share from continuing and discontinued operations	2.44	10.26
24	Debt equity ratio	0.0027	0.0027
25	Debt service coverage ratio	0.0849	0.0388
26	Interest service coverage ratio	0.0681	0.0904
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	58481500000
	Capital work-in-progress	4039100000
	Investment property	0
	Goodwill	41941600000
	Other intangible assets	3814700000
	Intangible assets under development	26300000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	1689800000
	Non-current financial assets
	Non-current investments	1200000
	Trade receivables, non-current	0
	Loans, non-current	22900000
	Other non-current financial assets	564100000
	Total non-current financial assets	588200000
	Deferred tax assets (net)	3145500000
	Other non-current assets	1543600000
	Total non-current assets	115270300000
2	Current assets
	Inventories	1153000000
	Current financial asset
	Current investments	0
	Trade receivables, current	7844900000
	Cash and cash equivalents	1397200000
	Bank balance other than cash and cash equivalents	3682700000
	Loans, current	17500000
	Other current financial assets	108000000
	Total current financial assets	13050300000
	Current tax assets (net)	6931400000
	Other current assets	510300000
	Total current assets	21645000000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	136915300000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	7549600000
	Other equity	81615600000
	Total equity attributable to owners of parent	89165200000
	Non controlling interest	2528700000
	Total equity	91693900000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	23113200000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	7500000
	Total non-current financial liabilities	23120700000
	Provisions, non-current	1629200000
	Deferred tax liabilities (net)	4398300000
	Deferred government grants, Non-current	0
	Other non-current liabilities
	Total non-current liabilities	29148200000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1637800000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	1062800000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	7013400000
	Total Trade payable	8076200000
	Other current financial liabilities	3801800000
	Total current financial liabilities	13515800000
	Other current liabilities	1637900000
	Provisions, current	589800000
	Current tax liabilities (Net)	329700000
	Deferred government grants, Current	0
	Total current liabilities	16073200000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	45221400000
	Total equity and liabilites	136915300000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Healthcare	17012000000	65280300000
2	Diagnostic	3484700000	14067400000
3	Intersegment	-424700000	-1520200000
	Total Segment Revenue	20072000000	77827500000
	Less: Inter segment revenue
	Revenue from operations	20072000000	77827500000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Healthcare	3003900000	10708100000
2	Diagnostic	328600000	1315200000
3	Intersegment	0	0
	Total Profit before tax	3332500000	12023300000
	i. Finance cost	675600000	675600000
	ii. Other Unallocable Expenditure net off Unallocable income	291400000	291400000
	Profit before tax	2365500000	10070400000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Healthcare	99289500000	99289500000
2	Diagnostic	21123000000	21123000000
3	Intersegment	-388200000	-388200000
	Total Segment Asset	120024300000	120024300000
	Un-allocable Assets	16891000000	16891000000
	Net Segment Asset	136915300000	136915300000
4	Segment Liabilities
	Segment Liabilities
1	Healthcare	14098600000	14098600000
2	Diagnostic	4443500000	4443500000
3	Intersegment	-388200000	-388200000
	Total Segment Liabilities	18153900000	18153900000
	Un-allocable Liabilities	27067500000	27067500000
	Net Segment Liabilities	45221400000	45221400000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit or loss	-56000000	-79700000
	Total Amount of items that will not be reclassified to profit and loss	-56000000	-79700000
2	Income tax relating to items that will not be reclassified to profit or loss	-16800000	-20000000
3	Amount of items that will be reclassified to profit and loss
1	Items that will be reclassified to profit or loss	8800000	24500000
	Total Amount of items that will be reclassified to profit and loss	8800000	24500000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-30400000	-35200000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			9955200000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			1844100000
	Adjustments for decrease (increase) in inventories			-86400000
	Adjustments for decrease (increase) in trade receivables, current			-2198900000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-66500000
	Adjustments for decrease (increase) in other non-current assets			-753800000
	Adjustments for other financial assets, non-current			950000000
	Adjustments for other financial assets, current			-45800000
	Adjustments for other bank balances			3200000
	Adjustments for increase (decrease) in trade payables, current			1043600000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			41300000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			3856200000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			893400000
	Adjustments for provisions, current			33100000
	Adjustments for provisions, non-current			-14000000
	Adjustments for other financial liabilities, current			-16612300000
	Adjustments for other financial liabilities, non-current			16600000000
	Adjustments for unrealised foreign exchange losses gains			7600000
	Adjustments for dividend income			0
	Adjustments for interest income			598300000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			100000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-34200000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			518300000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			5380700000
	Net cash flows from (used in) operations			15335900000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			1096600000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			14239300000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			278600000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			401000000
	Purchase of property, plant and equipment			8469400000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			8800000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			596500000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-52100000
	Net cash flows from (used in) investing activities	-7793800000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			17777400000
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			15500000000
	Proceeds from borrowings			113000000
	Repayments of borrowings			1984900000
	Payments of lease liabilities			519600000
	Dividends paid			1088700000
	Interest paid			1380800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-7138400000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-692900000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			-4600000
	Net increase (decrease) in cash and cash equivalents			-697500000
	Cash and cash equivalents cash flow statement at beginning of period			1696600000
	Cash and cash equivalents cash flow statement at end of period			999100000